Watch this presentation to learn
• Overview of the SNDS and the key working practices to access the database and ongoing SNDS developments
• Similarities and differences between SNDS and other claims databases
• Strengths and opportunities for HTAs and market access in Europe through case studies
• Stakeholder perspectives: current and potential benefits to patients, medical practices, health systems and pharmaceutical/biotech companies
講演者：Nadia Quignot, PhD Director, Decision Analytics & Real World Evidence, Certara
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
